Literature DB >> 15911851

Treating HIV/AIDS and leishmaniasis coinfection in Ethiopia.

Aranka Anema1, Koert Ritmeijer.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15911851      PMCID： PMC557972          DOI： 10.1503/cmaj.050511

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Prevalence of Leishmania infection among AIDS patients.

Authors:  J Alvar; B Gutiérrez-Solar; R Molina; R López-Velez; A Garcia-Camacho; P Martinez; F Laguna; E Cercenado; A Galmes
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

Authors:  K Ritmeijer; H Veeken; Y Melaku; G Leal; R Amsalu; J Seaman; R N Davidson
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Nov-Dec       Impact factor: 2.184
  2 in total
  9 in total

1.  HIV/AIDS and leishmaniasis coinfection in Ethiopia.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 3.  Eco-epidemiology of visceral leishmaniasis in Ethiopia.

Authors:  Endalamaw Gadisa; Teshome Tsegaw; Adugna Abera; Dia-Eldin Elnaiem; Margriet den Boer; Abraham Aseffa; Alvar Jorge
Journal:  Parasit Vectors       Date:  2015-07-19       Impact factor: 3.876

4.  Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia.

Authors:  Solomon Yared; Kebede Deribe; Araya Gebreselassie; Wessenseged Lemma; Essayas Akililu; Oscar D Kirstein; Meshesha Balkew; Alon Warburg; Teshome Gebre-Michael; Asrat Hailu
Journal:  Parasit Vectors       Date:  2014-10-14       Impact factor: 3.876

5.  Genome wide comparison of Ethiopian Leishmania donovani strains reveals differences potentially related to parasite survival.

Authors:  Arie Zackay; James A Cotton; Mandy Sanders; Asrat Hailu; Abedelmajeed Nasereddin; Alon Warburg; Charles L Jaffe
Journal:  PLoS Genet       Date:  2018-01-09       Impact factor: 5.917

6.  Clinical and laboratory profiles of visceral leishmaniasis among adult patients admitted to Felege Hiwot Hospital, Bahir Dar, Ethiopia.

Authors:  Berhanu Tarekegn; Ayanaw Tamene
Journal:  SAGE Open Med       Date:  2021-07-31

7.  Visceral Leishmaniasis in Benishangul-Gumuz Regional State, Western Ethiopia: Reemerging or Emerging?

Authors:  Adugna Abera; Geremew Tasew; Teshome Tsegaw; Asfaw Kejella; Abate Mulugeta; Dagimlidet Worku; Abraham Aseffa; Endalamaw Gadisa
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

Review 8.  Visceral leishmaniasis in eastern Africa--current status.

Authors:  Richard Reithinger; Simon Brooker; Jan H Kolaczinski
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-07-16       Impact factor: 2.184

Review 9.  One Health Approach Prospect for Integrated Control and Elimination of Visceral Leishmaniasis in Ethiopia: A Narrative Review Article.

Authors:  Tadesse Hailu
Journal:  Iran J Parasitol       Date:  2016 Jan-Mar       Impact factor: 1.012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.